These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24406078)

  • 61. BRAF as a melanoma susceptibility candidate gene?
    Laud K; Kannengiesser C; Avril MF; Chompret A; Stoppa-Lyonnet D; Desjardins L; Eychene A; Demenais F; Lenoir GM; Bressac-de Paillerets B;
    Cancer Res; 2003 Jun; 63(12):3061-5. PubMed ID: 12810628
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel mechanisms of MITF regulation identified in a mouse suppressor screen.
    Vu HN; Valdimarsson MM; Sigurbjörnsdóttir S; Bergsteinsdóttir K; Debbache J; Bismuth K; Swing DA; Hallsson JH; Larue L; Arnheiter H; Copeland NG; Jenkins NA; Heidarsson PO; Steingrímsson E
    EMBO Rep; 2024 Oct; 25(10):4252-4280. PubMed ID: 39169200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.
    Hashimoto Y; Ito Y; Kato T; Motokawa T; Katagiri T; Itoh M
    J Cutan Pathol; 2006 Mar; 33(3):207-15. PubMed ID: 16466507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 65. A De Novo MITF Deletion Explains a Novel Splashed White Phenotype in an American Paint Horse.
    Magdesian KG; Tanaka J; Bellone RR
    J Hered; 2020 May; 111(3):287-293. PubMed ID: 32242630
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
    Bruno W; Pastorino L; Ghiorzo P; Andreotti V; Martinuzzi C; Menin C; Elefanti L; Stagni C; Vecchiato A; Rodolfo M; Maurichi A; Manoukian S; De Giorgi V; Savarese I; Gensini F; Borgognoni L; Testori A; Spadola G; Mandalà M; Imberti G; Savoia P; Astrua C; Ronco AM; Farnetti A; Tibiletti MG; Lombardo M; Palmieri G; Ayala F; Ascierto P; Ghigliotti G; Muggianu M; Spagnolo F; Picasso V; Tanda ET; Queirolo P; Bianchi-Scarrà G
    J Am Acad Dermatol; 2016 Feb; 74(2):325-32. PubMed ID: 26775776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
    Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.
    Katoh I; Mírová A; Kurata S; Murakami Y; Horikawa K; Nakakuki N; Sakai T; Hashimoto K; Maruyama A; Yonaga T; Fukunishi N; Moriishi K; Hirai H
    Neoplasia; 2011 Nov; 13(11):1081-92. PubMed ID: 22131883
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
    Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
    Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
    J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The melanocortin-1-receptor gene is the major freckle gene.
    Bastiaens M; ter Huurne J; Gruis N; Bergman W; Westendorp R; Vermeer BJ; Bouwes Bavinck JN
    Hum Mol Genet; 2001 Aug; 10(16):1701-8. PubMed ID: 11487574
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue.
    Bauer GL; Praetorius C; Bergsteinsdóttir K; Hallsson JH; Gísladóttir BK; Schepsky A; Swing DA; O'Sullivan TN; Arnheiter H; Bismuth K; Debbache J; Fletcher C; Warming S; Copeland NG; Jenkins NA; Steingrímsson E
    Genetics; 2009 Oct; 183(2):581-94. PubMed ID: 19635938
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MITF in melanoma: mechanisms behind its expression and activity.
    Hartman ML; Czyz M
    Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma.
    Strange RC; Ellison T; Ichii-Jones F; Bath J; Hoban P; Lear JT; Smith AG; Hutchinson PE; Osborne J; Bowers B; Jones PW; Fryer AA
    Pharmacogenetics; 1999 Jun; 9(3):269-76. PubMed ID: 10471058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Germline mutations predisposing to melanoma.
    Toussi A; Mans N; Welborn J; Kiuru M
    J Cutan Pathol; 2020 Jul; 47(7):606-616. PubMed ID: 32249949
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid melanoma induction in mice expressing oncogenic Braf
    Urtatiz O; Samani AMV; Kopp JL; Van Raamsdonk CD
    Pigment Cell Melanoma Res; 2018 Jul; 31(4):541-544. PubMed ID: 29266793
    [No Abstract]   [Full Text] [Related]  

  • 80. Indoor tanning exposure in association with multiple primary melanoma.
    Karapetyan L; Yang X; Wang H; Sander CA; Moyer A; Wilson M; Karunamurthy A; Kirkwood JM
    Cancer; 2021 Feb; 127(4):560-568. PubMed ID: 33170961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.